A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung Cancer
Clinical trial NCT06984588 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06984588
- Sponsor
- TJ Biopharma Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-28
- Primary completion
- 2028-08-05
- Enrollment
- 450
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.